March 7, 2023 - EX-3.1 - 10-K: Annual report pursuant to Section 13 and 15(d) | Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 7, 2023

Documents

Exhibit 3.1

img90588597_0.jpg 

 

img90588597_1.jpg 

img90588597_2.jpg 

img90588597_3.jpg 

img90588597_4.jpg 

img90588597_5.jpg 

img90588597_6.jpg 

img90588597_7.jpg 

img90588597_8.jpg 

img90588597_9.jpg 

img90588597_10.jpg 

img90588597_11.jpg 

img90588597_12.jpg